All posts by " effepharm "

Recent Posts

Recent Comments

    EffePharm and Shanghai Jiao Tong University Announce Strategic Collaboration

    — Exploring the Anti-Aging Mechanisms and Health Potential of NMN and NMNH —   July 9, 2024, SHANGHAI – EffePharm is pleased to announce the signing of a significant three-year collaboration agreement with the team of Dr. Zheng Songguo from Shanghai Jiao Tong University. This collaboration is part of EffePharm’s latest effort to explore, develop, […]

    Read more

    EffePharm’s Success at SupplySide West 2023

    SHANGHAI, China—EffePharm, the trailblazing biotech company, takes a moment to appreciate the incredible journey experienced at SupplySide West 2023, held at Mandalay Bay in Las Vegas. The event marked the introduction of UthPeak™, a captivating newcomer to the “Uth” series, EffePharm’s esteemed flagship NAD+ booster line. The atmosphere at the EffePharm booth was nothing short […]

    Read more

    EffePharm to Launch UthPeak™ at SupplySide West 2023

    EffePharm to Launch UthPeak™ at SupplySide West 2023 New member of the “Uth series” – EffePharm’s flagship NAD+ booster line SHANGHAI, China—Industry leading biotech company EffePharm will unveil its Next-Gen NAD+ Booster, UthPeak™, at booth #4965 during the SupplySide West 2023 from October 25 to 26 at Mandalay Bay in Las Vegas.   At booth […]

    Read more

    Subacute Toxicity of NMN

    The administration of Nicotinamide mononucleotide(NMN) which is a key precursory metabolite of NAD+ has been reported to have remarkable therapeutic effects on age-related diseases. However systemic evaluation pertaining to the subacute toxicity of NMN remains to be determined.   Recently, the Shanghai Institute of Organic Chemistry conducted a study about the subacute toxicity of NMN […]

    Read more

    Hi Mrs, NMN Helps Pregnancy

    With the increasing, late marriage and late childbirth in China, as well as the two-child policy, and even the looming phenomenon of the third child in some regions, the group of elderly pregnant women has begun to approach the public’s vision. A variety of problems derived from it also appear egg quality decline, organ function […]

    Read more

    NMN, A Heart Disease Terminator

    As the engine of the human body, the heart occupies an incomparable position in the body. Obligations, however, go hand in hand with responsibilities. The fate of the heart is from birth to work to death, but why is the difference so great between individuals? While some people go into cardiac arrest at 50, centenarians […]

    Read more

    What are the changes NMN can visibly make on you?

    Since the nicotinamide mononucleotide (NMN) was found to promote the increase of NAD+ in the body, the scientific research on its anti-aging effect in an endless stream of studies, and some even dubbed it a “longevity drug”. However, whether NMN promotes NAD+ in the body, or repairs DNA and inhibits aging signs in related organs, […]

    Read more

    NMN Has Anti-Aging Potential for Kidneys

    The world’s population of older adults continues to expand at an unprecedented pace. So, there is a need for a better understanding of aging processes to mitigate age-related diseases and disorders. But not all organs age at the same pace, so it’s important for scientists to characterize aging processes for each organ. Recently, Deng and […]

    Read more

    How does NMN work in Sirtfood Diet?

    It’s common knowledge that health and longevity go hand in hand with diet, which has encouraged many people to pay close attention to what they eat. Although restricting calorie intake and fasting are proven methods to promote weight loss and longevity, it’s not an easy or exciting thing to do every day. But wouldn’t it […]

    Read more

    Meet us at CPhi 2020 at E5A08

    From 16Dec to 18Dec 2020, Effepharm will attend CPhi 2020 in Shanghai, China. As an exhibitor, our booth will be E5A08 At the expo, Effepharm will introduce its next-generation NMN – Uthever® to our customers and the public. Looking forward to meeting you at CPhi 2020.

    Read more